The European Commission approved RINVOQ for non-segmental vitiligo and, the same day, for severe alopecia areata, both in adults and adolescents aged 12 and over.
Organon, a global healthcare company dedicated to improving the health of women throughout their lives, has announced the acquisition of Dermavant Sciences Ltd., a dermatology-focused subsidiary of Roivant Sciences. This acquisition will broaden Organon’s dermatology capabilities in the U.S. and beyond. The move aligns with Organon’s long-term strategy of expanding into therapeutic areas with high … Read more